Syndax Names Aaron A. Ondrey CFO, Effective Nov. 9

PUBT · 20h ago
Syndax Names Aaron A. Ondrey CFO, Effective Nov. 9
  • Syndax Pharmaceuticals appointed Aaron A. Ondrey chief financial officer, effective November 9, 2026.
  • Outgoing CFO Keith A. Goldan will retire from the role, remaining through year-end 2026 to support the transition.
  • Ondrey most recently served as CFO of Beren Therapeutics, overseeing finance, investor relations and manufacturing operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021601PRIMZONEFULLFEED9868375) on November 02, 2026, and is solely responsible for the information contained therein.